The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ho Robert since 2021.
This trader's CIK number is 1806254.
At the time of last reporting, Ho Robert was the Chief Financial Officer of Neoleukin Therapeutics, Inc.. (stock ticker symbol NLTX).
Also see all insider trading activities at Neoleukin Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | NLTX | 0 | $0 | 6,497 | $71,557 | 25,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-17 | NLTX | Sale | 6,497 | 11.01 | 71,557 |
| 2021-03-16 | NLTX | Option Ex | 25,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Robert (Chief Financial Officer of Neoleukin Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.